Henrietta, NY, United States of America

Robert Dingman

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The State University of New York. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Dingman. Retrieved from https://idiyas.com/inventor/robert-dingman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Robert Dingman

Introduction

Robert Dingman is an accomplished inventor based in Henrietta, NY (US). He has made significant contributions to the field of immunology through his innovative work. With a total of 3 patents, Dingman has focused on developing compositions that induce immune tolerance.

Latest Patents

Dingman's latest patents include "Phosphoserine containing compositions for immune tolerance induction." These compositions and methods are designed to induce immune tolerance to proteins, allowing for subsequent administration of these proteins. The compositions comprise proteins complexed with liposomes that include phosphoserine (PS) and phosphatidylcholine (PC), wherein at least part of the PS is present as lyso-PS.

Career Highlights

Dingman is affiliated with the State University of New York, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in therapeutic settings.

Collaborations

Some of his notable coworkers include Sathy Balu-Iyer and Richard Bankert, who have collaborated with him on various projects.

Conclusion

Robert Dingman's contributions to immunology through his patented innovations highlight his role as a significant figure in the field. His work continues to pave the way for advancements in immune tolerance therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…